This bill amends Maine's insurance code to explicitly include the MaineCare program as a "carrier" for prescription drug benefit purposes. The change clarifies that MaineCare, which provides health coverage to low-income residents, is treated similarly to private insurance carriers under state insurance regulations. By adding MaineCare to the definition of carrier, the legislation ensures the program falls under existing insurance code provisions governing prescription drug benefits. This adjustment affects how MaineCare is classified within the state's insurance framework without altering the program's core eligibility or funding structure.
LD 2004 modifies Maine's existing Fund To Address Food Insecurity and Provide Nutrition Incentives to better support local programs. It allows the fund to match private/public contributions up to $50,000 annually, prioritizing Maine-based organizations with experience helping low-income residents use federal food assistance (like SNAP) to buy locally grown fruits and vegetables. The bill requires organizations applying for funds to demonstrate how they will leverage the money or have a history of promoting local food access. It also mandates regular reporting and audits to ensure funds are used appropriately for nutrition incentive programs.
LD 697 directs Maine's Prescription Drug Affordability Board to set annual spending targets for prescription drugs purchased by state and local government health plans (excluding MaineCare), using a formula based on a 10-year average of medical care costs plus inflation, minus savings. The board must assess cost-reduction strategies, including reference-based pricing - which aligns drug prices with those in other regions - and establish a 12-member advisory council with representatives from state agencies, labor unions, and consumer groups to advise on setting targets and methods. The board will also identify public payors (state, county, and municipal health plans) likely to exceed the spending targets.
LD 858 creates a state grant program to help schools access behavioral and mental health services for students. It provides schools with $3,000 to $9,000 annually based on student population (e.g., $9,000 for schools over 500 students) to contract with licensed external providers. The grants cannot cover services already paid for by MaineCare, and funds must supplement - not replace - existing school mental health staff. This program, funded at $1.353 million yearly starting in 2025-26, directly supports school districts in expanding student mental health resources.
LD 163 requires all health insurance plans in Maine covering prescription drugs or outpatient services to fully cover federally approved nonprescription oral hormonal contraceptives and emergency contraceptives without any deductibles, copays, or coinsurance. This applies directly to health insurers and enrollees, eliminating out-of-pocket costs for these specific contraceptives. The bill clarifies that no prescription is needed to obtain these items, and coverage must include supplies for a full 12-month period. It specifically excludes coverage for abortion-inducing drugs. The law updates Maine’s health insurance coverage requirements to align with federal contraceptive approvals.
LD 117 provides $1.23 million in state funding for sexual assault services during the 2025-2026 fiscal year, increasing to $1.83 million for 2026-2027. The funds are allocated through the Department of Health and Human Services' Purchased Social Services program to directly support local sexual assault service providers. This funding covers essential services like crisis counseling, medical advocacy, and legal support for survivors. The bill does not create new programs but ensures sustained financial support for existing services across Maine.
LD 93 expands Maine's Universal Childhood Immunization Program to cover all adults residing in the state, not just children under 19. The bill amends existing law to define "individual" as any Maine resident and modifies program administration to include adults in the vaccine coverage. It maintains the same funding mechanism through the Childhood Immunization Fund, requiring assessed entities (like insurance providers) to pay quarterly assessments based on the number of covered residents. This change aims to reduce costs and increase access to recommended vaccines for all age groups by extending the existing childhood program framework.
LD 82 extends a permanent presumption in Maine's workers' compensation law that automatically considers post-traumatic stress disorder (PTSD) work-related for certain public safety workers. This applies to law enforcement officers, corrections officers, E-9-1-1 dispatchers, firefighters, and emergency medical services personnel diagnosed with PTSD. Currently, this presumption was set to expire on October 1, 2025, but the bill removes that expiration date. As a result, these workers no longer need to prove their PTSD was caused by job duties to qualify for compensation benefits.
LD 1266 requires Maine's Attorney General to form a working group to create a plan expanding access to adult drug, family, and veterans treatment courts statewide. The group must include stakeholders like courts, corrections, health departments, prosecutors, and advocacy organizations to ensure every county has access to these specialty courts for defendants whose criminal involvement relates to substance use disorders. The working group must submit its recommendations and suggested legislation to the Judiciary Committee by January 1, 2026. This resolve does not change current law but directs a study to improve access to treatment-based court options.
LD 613 amends Maine's Death with Dignity Act to allow attending physicians to waive any portion or all of the waiting periods required for qualified patients to access end-of-life medication, based on the physician's medical assessment of the patient's condition. Physicians must document the waiver, including the specific portion waived and the medical reasoning that it serves the patient's best interests. This change directly affects patients eligible under Maine's Death with Dignity Act and their attending physicians. The amendment aims to improve timely access for patients facing urgent health circumstances without requiring the full waiting period.
